“…Myxopapillary ependymoma and subependymoma have a favorable prognosis, late recurrences and distant metastases being very uncommon. According to some authors tumor grade is the most important determinant of prognosis [5,33,34,[42][43][44][45], whereas others did not find any correlation between survival and histologic grade suggesting that the outcome is influenced by anatomical location, which influence resecability, rather than by pathological features [35,36,[46][47][48][49]. The 5-year survival for patients with low-grade tumors ranges 55-87%, whereas for anaplastic ependymomas it is 10-47% [33,37,43,50].…”